Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 2:10:1100483.
doi: 10.3389/fsurg.2023.1100483. eCollection 2023.

The paradox of Zeno in bariatric surgery weight loss: Superobese patients run faster than morbidly obese patients, but can't overtake them

Fabio Medas  1 , Enrico Moroni  2 , Simona Deidda  1 , Luigi Zorcolo  1 , Angelo Restivo  1 , Gian Luigi Canu  1 , Federico Cappellacci  1 , Pietro Giorgio Calò  1 , Stefano Pintus  2 , Giovanni Fantola  2
Affiliations

The paradox of Zeno in bariatric surgery weight loss: Superobese patients run faster than morbidly obese patients, but can't overtake them

Fabio Medas et al. Front Surg. .

Abstract

Introduction: Superobesity (SO) is defined as a BMI > 50 Kg/m2, and represents the extreme severity of the disease, resulting in a challenge for the surgeons.

Methods: In this retrospective study we aimed to compare the outcomes of SO patients compared to morbidly obese (MO) patients.

Results: We included in this study 154 MO patients, with a median preoperative BMI of 40.8 kg/m2, and 19 SO patients with median preoperative BMI of 54.9 kg/m2. The MO patients underwent sleeve gastrectomy (SG) in 62 (40.3%) cases, laparoscopic Roux-and-Y gastric bypass (LRYGBP) in 85 (55.2%) cases and One-Anastomosis Gastric Bypass (OAGB) in 7 (4.5%) cases. underwent OAGB. The patients in the SO group were submitted to SG in 11 (57.9%) cases, LRYGBP in 5 (26.3%) cases, and OAGB in 3 (15.8%). At 24-month follow-up, an excess weight loss (EWL) >50% was achieved in 129 (83.8%) patients in the MO group and in 15 (78.9%) in the SO group (p = 0.53). A BMI < 35 kg/m2 was achieved in 137 (89%) patients in the MO group and from 8 (42.2%) patients in the SO group (p < 0.001). The total weight loss was significantly directly related to the initial BMI. Superobesity was identified as independent risk factor for surgical failure when considering the outcome of BMI < 35 kg/m2.

Discussion: Our study confirms that, although SO patients tend to gain a greater weight loss than MO patients, they less frequently achieve the desired BMI target. In this setting, it should be necessary to re-consider malabsorptive procedures as first choice.

Keywords: laparoscopic Roux-and-Y gastric bypass; laparoscopic sleeve gastrectomy; morbidly obese patients; obesity surgery; superobesity.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Scatter diagram representing the correlation between preoperative BMI and total weight loss (TWL). The correlation test demonstrated that preoperative BMI > 50 Kg/m2 was significantly associated with a higher TWL (correlation coefficient = 0.4914; p < 0.001).
Figure 2
Figure 2
Forest plot of results of multivariate analysis. Results are reported in logarithmic scale. In (A) are reported the results of logistic regression considering the outcome of EWL > 50% at 24 months; the only significant variable predictive of surgical failure was SG (OR = 2.816; 95%CI = 1.0741–7.3837; p = 0.0353). In (B) are reported the results of logistic regression considering the outcome of BMI < 35 Kg/m2 at 24 months. The only significant variable predictive of surgical failure was superobesity (OR = 14.04; 95%CI = 3.5443–55.6861 p = 0.002). OR, odds ratio; OSAS, obstructive sleep apnea syndrome; GERD, gastroesophageal reflux disease; SG, sleeve gastrectomy; OAGBP, one-anastomosis gastric bypass.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med. (2017) 376:641–51. 10.1056/NEJMoa1600869 - DOI - PMC - PubMed
    1. Gomes-Rocha SR, Costa-Pinho AM, Pais-Neto CC, de Araújo Pereira A, Nogueiro JPM, Carneiro SPR, et al. Roux-en-Y gastric bypass vs sleeve gastrectomy in super obesity: a systematic review and meta-analysis. Obes Surg. (2022) 32:170–85. 10.1007/s11695-021-05745-8 - DOI - PubMed
    1. Verhoeff K, Mocanu V, Dang J, Purich K, Switzer NJ, Birch DW, et al. Five years of MBSAQIP data: characteristics, outcomes, and trends for patients with super-obesity. Obes Surg. (2022) 32:406–15. 10.1007/s11695-021-05786-z - DOI - PubMed
    1. Soong TC, Lee MH, Lee WJ, Almalki OM, Chen JC, Wu CC, et al. Long-term efficacy of bariatric surgery for the treatment of super-obesity: comparison of SG, RYGB, and OAGB. Obes Surg. (2021) 31:3391–9. 10.1007/s11695-021-05464-0 - DOI - PubMed
    1. Parmar CD, Bryant C, Luque-de-Leon E, Peraglie C, Prasad A, Rheinwalt K, et al. One anastomosis gastric bypass in morbidly obese patients with BMI ≥ 50 kg/m2: a systematic review comparing it with roux-en-Y gastric bypass and sleeve gastrectomy. Obes Surg. (2019) 29:3039–46. 10.1007/s11695-019-04034-9 - DOI - PubMed

LinkOut - more resources